The idea sounds like something lifted from science fiction - a human eye, removed from a donor hours after death, still responding to flashes of light.
As ophthalmologists emphasise, the study is about preserving retinal cells in a carefully controlled laboratory environment, not restoring vision after death.
This vulnerability has long limited scientists’ ability to study living human retinal tissue and has complicated efforts to develop future regenerative therapies.
One of the biggest obstacles in ophthalmology has been the inability to study living human retinal tissue.
Nevertheless, preserving functional human retinal responses for 10 hours after death represents an important technical milestone.
The idea sounds like something lifted from science fiction - a human eye, removed from a donor hours after death, still responding to flashes of light. Well, that’s not us saying but a study conducted by Dr Eimear Byrne at the Centre for Genomic Regulation.
By keeping donated eyes supplied with oxygen and nutrients through an artificial circulation system, scientists have preserved retinal function for up to 10 hours after death, doubling the previous benchmark.
STORY CONTINUES BELOW THIS AD
The advance does not mean the eyes have been brought back to life, nor does it suggest that consciousness persists after death. Instead, it offers an important glimpse into how remarkably resilient some nerve cells can be under the right conditions and could help scientists develop better treatments for blinding eye diseases.
The findings have generated considerable excitement in ophthalmology, but they have also prompted misconceptions.
As ophthalmologists emphasise, the study is about preserving retinal cells in a carefully controlled laboratory environment, not restoring vision after death.
A race against time
The retina is one of the most metabolically active tissues in the human body.
Located at the back of the eye, it converts light into electrical signals that travel through the optic nerve to the brain, where they are interpreted as vision.
Unlike many other tissues, the retina has almost no tolerance for interruptions in its oxygen supply. Within minutes of blood circulation stopping, its specialised neurons begin losing function.
This vulnerability has long limited scientists’ ability to study living human retinal tissue and has complicated efforts to develop future regenerative therapies.
To overcome this challenge, researchers developed a custom perfusion system that supplied donated eyes with oxygen and nutrients through the ophthalmic artery, mimicking natural blood circulation. Instead of rapidly deteriorating, the retinas maintained their structure for up to 24 hours, while electrical recordings showed that many continued responding to light for as long as 10 hours after the donor’s death.
STORY CONTINUES BELOW THIS AD
What “responding to light” actually means
This is where the headlines need careful interpretation.
The researchers detected electrical activity generated by retinal cells when exposed to light. That demonstrates that the retina’s photoreceptor cells remained biologically active. It does not mean the eye was capable of seeing.
Vision depends on much more than a functioning retina. The electrical signals produced by retinal cells must travel through an intact optic nerve and reach the brain’s visual centres. Once the optic nerve is no longer connected, that pathway is lost.
Dr Rashmi Barve, Consultant Ophthalmology at KIMS Hospitals, Thane, says the study demonstrates that retinal cells, particularly photoreceptors, can retain biological activity for longer than previously thought if provided with the right environment. “This does not mean that vision can be restored after death or that the eye remains functional for several hours after a person dies.”
Why this matters for patients
The real significance of the research lies not in reviving eyes, but in understanding diseases that rob people of their sight.
According to the World Health Organization, at least 2.2 billion people worldwide live with vision impairment or blindness, and at least one billion of those cases could have been prevented or have yet to be addressed.
STORY CONTINUES BELOW THIS AD
Retinal diseases, including age-related macular degeneration, diabetic retinopathy and inherited retinal disorders, are among the leading causes of irreversible blindness. Their burden continues to grow in India because of an ageing population and the increasing prevalence of diabetes.
One of the biggest obstacles in ophthalmology has been the inability to study living human retinal tissue. Much of our understanding comes from animal models, but the human retina differs significantly in both structure and function.
Dr Chitralekha De, Senior Consultant in Ophthalmology at Amrita Hospital, Faridabad, says this research gives scientists “a rare opportunity to observe how human retinal cells behave, how diseases progress and how new medicines, gene therapies and regenerative treatments can be tested more accurately before reaching patients.”
Building on earlier breakthroughs
The latest work builds on a landmark study published in Nature in 2022, in which researchers restored light responses in human retinal cells obtained from donor eyes up to five hours after death. That study identified oxygen deprivation and tissue acidification as major reasons why retinal function rapidly declines after circulation stops.
The new research extends that window to approximately 10 hours by maintaining the entire eye under carefully controlled physiological conditions before irreversible damage occurs.
Although whole-eye transplantation remains beyond current medical capabilities because reconnecting the optic nerve is still not possible, preserving healthy retinal tissue for longer could prove valuable as regenerative medicine advances.
STORY CONTINUES BELOW THIS AD
The importance of eye donation
The study also highlights an often-overlooked aspect of medical research: eye donation.
Donated corneas already restore sight to thousands of people every year. Donated retinal tissue, while not used directly for transplantation in the same way, allows researchers to study human disease in unprecedented detail and may help develop treatments that benefit millions in the future.
Dr De believes this research reinforces the value of eye donation beyond corneal transplantation. “Although not an immediate clinical breakthrough, this is an important step towards the development of better treatments for blinding retinal diseases and for the future of vision science.”
Dr Barve agrees that the discovery remains experimental but says it provides researchers with a unique opportunity to explore new approaches to preserving and restoring vision. Translating these findings into clinical practice, she notes, will require extensive research and validation.
Looking ahead
The Eye-in-Care-Box system is unlikely to bring sight-restoring eye transplants into hospitals any time soon. Significant scientific hurdles remain, particularly the challenge of repairing or regenerating the optic nerve.
Nevertheless, preserving functional human retinal responses for 10 hours after death represents an important technical milestone. It gives researchers unprecedented access to living human retinal tissue, improves opportunities to study blinding diseases, and could accelerate the development of new medicines, gene therapies and regenerative treatments.
STORY CONTINUES BELOW THIS AD
Sometimes scientific progress is measured not in dramatic breakthroughs, but in expanding the possibilities for future discovery.
In this case, gaining a few extra hours of retinal function after death could ultimately help protect the sight of millions of people living with retinal disease.
)
